Skip to main content

Table 3 Outcomes

From: Short term clinical outcomes and analysis of risk factors for pacemaker implantation: a single center experience of self-expandable TAVI valves

Procedural outcomes  
30 day all cause mortality 5/88 (5.7%)
1 year actuarial all cause mortality 14/84 (16.7%)
Kaplan Meier 1 year all cause survival 83.3%
Causes of death (1 year) * n = 14  
Sepsis 3/14 (21.4%)
Renal failure 1/14 (7.1%)
Pacing wire ventricular perforation 1/14 (7.1%)
Root rupture 1/14 (7.1%)
Myocardial infarction 3/14 (21.4%)
Congestive heart failure 2/14 (14.5%)
Stroke 3/14 (21.4%)
Cardiovascular death at 1 year 10/84 (11.9%)
Major Vascular complications 8/88 (8%)
Coronary obstruction 2/88 (2.3%)
30 day disabling stroke risk 5/88 (5.7%)
30 day Acute kidney injury with renal replacement therapy 6/88 (6.8%)
Device success rate (defined as single valve,with no moderate to severe PVL, mean gradient < 20 mmHg) 88.6%
1 year Prosthetic valve endocarditis 2/84 (2.4%)
1 year Repeat valvular intervention 1/84 (1.2%)
30 Day Pacemaker rates (n = 85 *3 cases of pre op PPM excluded) 15/85 (17.6%)
Moderate or more paravalvular leak (PVL) on 1 year echocardiogram 5/84 (6.0%)
Repeated cardiac events (angina, MI, heart failure) requiring admissions within 1 year 7/84 (8.3%)